“We are already observing an increase of around 100 basis points,” Reddy stated, highlighting how a tightening cost environment is affecting healthcare investments. Nonetheless, she assured that the sector retains its resilience, supported by structural demand and long-term growth potential.
Her statements come at a time when global uncertainties have escalated due to the ongoing conflict in West Asia, with oil prices consistently above $100 a barrel and rising concerns regarding inflation, trade deficits, and overall economic growth. Increased input and financing costs are starting to permeate various sectors, including healthcare, which depends on both capital expenditure and consistent management of operational costs.
Reddy pointed out that ensuring affordability will be crucial as expenses climb. “The most significant challenge is definitely related to whether we can maintain the value proposition of affordable healthcare in India,” she mentioned, adding that with improved insurance penetration, nearly half the population can now access healthcare services, making cost stability vital.
She emphasized that pressures from both operational and capital expenditures are emerging. Even as operational costs escalate, the priority remains on ensuring that growth plans proceed without disruption. “On the CAPEX side, how do we sustain our focus on growth? This sector possesses robust growth potential,” she remarked.
Furthermore, Reddy highlighted the need for structural changes to manage costs more efficiently. Diversifying supply chains represents one such strategy, especially in a volatile global landscape. She also noted that trade policy plays a crucial role, as customs duties account for a significant portion of project expenditures and may need reassessment in ongoing trade deliberations.
Also Read | Health insurance may become as important as roads and power in India’s 2047 growth story
Despite immediate pressures, she affirmed that India’s healthcare sector continues to stand out on a global scale. The nation’s capability to provide high-quality care at relatively low costs has attracted international patients, and this advantage is anticipated to continue. “There is a structural demand for healthcare, and we keep attracting foreign patients due to our innovative low-cost healthcare delivery,” she stated.
Looking forward, Reddy recognized medical technology as the next significant opportunity. “The next frontier lies in reinventing how we manufacture medical equipment at one-tenth the cost of what it is in the United States,” she remarked, indicating a potential shift towards domestic innovation and cost-efficient production.
Her insights suggest that while rising capital costs and global challenges are presenting short-term obstacles, the healthcare sector’s fundamentals remain stable, bolstered by consistent demand, innovation, and its essential role within the economy.
